Adaptive Biotechnologies Corporation: JP Morgan raises target price to $35 from $30
ADPT•JP Morgan raised its target price for Adaptive Biotechnologies Corporation to $35 from $30.
Related News
Humana publishes Q3 2026 earnings call transcript
HUM•
Why Taiwan’s AI moat trumps South Korea's memory bet: Manishi Raychaudhuri
SMH•
FF EAI Robotics' OmniMind ranks No. 1 on RoboColiseum embodied AI leaderboard
FFAI•
Watts Water Technologies: Stifel cuts target price to $430 from $445
WTS•
Raymond James cuts Axon Enterprise target price to $475 from $675
AXON•